Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof
CA 2529941 C · Owner: Groux, Herve · Inventors: Groux, Herve
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for identification of Tr1 lymphocyte regulators in a biological sample based on the determination of the simultaneous presence of the molecular group CD4 CD18 and/or CD11a, CD49b and, where appropriate by the demonstration of an over-expression of genes coding for the molecules CD4 PSGL-1, PECAM-1 and alphaV/beta3. The invention further relates to a method of quantification and a prognostic or diagnostic method for auto-immune or inflammatory diseases based on said identification method. The invention also relates to an enrichment method for Tr1 lymphocyte regulators based on the determination of the simultaneous presence of said molecules and finally, an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 24, 2004 and granted August 13, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 24, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 24, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.